Chemoprevention of lung cancer

Current Opinion in Pulmonary Medicine

Volumn 10, Issue 4, 2004, Pages 279-283

  Cohen, Victor ^a   Khuri, Fadlo R ^b  

^a MCGILL UNIVERSITY   (Canada)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoprevention; Field carcinogenesis; Lung cancer; Multistep carcinogenesis; Retinoids

Indexed keywords

ACETYLCYSTEINE; ALITRETINOIN; ALPHA TOCOPHEROL; BETA CAROTENE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ETRETINATE; FENRETINIDE; GEFITINIB; ILOPROST; ISOTRETINOIN; LONAFARNIB; RETINOID; RETINOL; RETINOL PALMITATE; ROFECOXIB; TIPIFARNIB;

CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DISEASE ACTIVITY; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; PATHOPHYSIOLOGY; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 3042578378     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcp.0000129754.97392.d5     Document Type: Review

References (36)

1. Lung cancer: In: BW Stewart and P Kleihues (eds). World Cancer Report. Lyon, France: IARC Press, 2003:182-187.
2. th edition. Philadelphia: Lippincott-Raven, 2001:925-983.
3. Sporn MB, Dunlop NM, Newton DL, et al.: Prevention of chemical carcinogenesis by vitamin A and its synthetic analogues. Fed Proc 1976, 35:1332-1338.
4. Gail M, Brinton L, Byar D, et al.: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886.
5. Fisher B, Constantino JP, Wickerham DL, et al.: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998, 90:1371-1388.
6. Steinbach G, Lynch PM, Phillips RK, et al.: The effects of celecoxib, a cyclooxygenase inhibitor, in familial adenomatous polyposis. N Engl J Med 2000, 342:1946-1952.
7. Hong WK, Endicott J, Itri LM, et al.: 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986, 315:1501-1505.
8. Hong WK, Lippman SM, Itri LM, et al.: Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990, 323:795-801.
9. Auerbach O, Stout AP, Hammond EC, et al.: Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 1961, 265:253-267.
10. Mao L, Lee JS, Kurie JM, et al.: Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997, 89:857-862.
11. Wistuba II, Lam S, Behrens C, et al.: Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997, 89:1366-1373.
12. Hong WK, Sporn MB: Recent advances in chemoprevention of cancer. Science 1997, 278:1073-1077.
13. Alpha-tocopherol: Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 1994, 330:1029-1035.
14. Omenn GS, Goodman GE, Thornquist MD, et al.: Effects of a combination of beta-carotene and vitamin A and cardiovascular disease. N Engl J Med 1996, 334:1150-1155.
15. Block G, Patterson B, Subar A: Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992, 18:1-29.
16. van Poppel G, Goldbohm RA: Epidemiologic evidence for beta-carotene and cancer prevention. Am J Clin Nutr 1995, 62:13933-14023.
17. Menkes MS, Comstock GW, Vuilleumier JP, et al.: Serum beta-carotene, vitamins A and E, selenium and the risk of lung cancer. N Engl J Med 1986, 315:1250-1254.
18. Stryker WS, Kaplan LA, Stein EA, et al.: The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 1988, 127:283-296.
19. Greenwald P: Beta-carotene and lung cancer: A lesson for future chemoprevention investigations? J Natl Cancer Inst 2003, 95:E1. An excellent and comprehensive review of the issues surrounding the ATBC and CARET studies. It offers a number of possible reasons why the results of these trials differed from the many epidemiologic observations showing an association between reduced lung cancer risk and higher fruit and vegetable intake and higher serum beta-carotene.
20. Lee JS, Lippman SM, Benner SE, et al.: Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 1994, 12:937-945.
21. Kurie JM, Lee JS, Khuri FR, et al.: N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res 2000, 6:2973-2979.
22. Arnold AM, Browman GP, Levine MN, et al.: The effect of the synthetic retinoid etredinate on sputum cytology: results from a randomized trial. Br J Cancer 1992, 65:737-743.
23. McLarty JW, Holiday DB, Girard WM, et al.: Beta-carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr 1995, 62:1431S-1438S.
24. Heimbuger DC, Alexander CB, Birch, et al.: Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized double-blind intervention trial. JAMA 1988, 259:1525-1530.
25. Kurie JM, Lotan R, Lee JS, et al.: Randomized, placebo-controlled tiral of 9-cis-retinoic acid versus 13-cis-retinoic acid plus alpha-tocopherol in the reversal of biomarkers of bronchial preneoplasia in former smokers (unpublished data). A randomized placebo-controlled trial showing that 9-cis-retinoid acid can restore RAR-beta expression in the bronchial epithelium raising the possibility that this retinoid has potential chemopreventive properties in former smokers.
26. Khuri FR, Lotan R, Kemp B, et al.: Retinoic acid receptor-beta as a prognostic indicator in stage I non-small cell lung cancer. J Clin Oncol 2000, 18:2798-2804.
27. Lam S, MacAulay C, Le Riche JC, et al.: A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst 2002, 94:1001-1009. The results of this study suggest that in smokers, ADT is a potential efficacious chemoprevention agent for lung cancer.
28. Pastorino U, Infante M, Maioli M, et al.: Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993, 11:1216-1222.
29. van Zandwijk N, Dalesio O, Pastorino U, et al.: EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst 2000, 92:977-986.
30. Lippman SM, Lee JJ, Karp DD, et al.: Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001, 93:605-618.
31. Mayne ST, Cartmel B, Baum M, et al.: Randomized trial of supplemental beta-carotene to prevent second head and neck cancer. Cancer Res 2001, 61:1457-1463.
32. Khuri FR, Lee JJ, Lippman SM, et al.: Isotretinoin effects on head and neck cancer recurrence and second primary tumors. Proc Am Soc Clin Oncol. 2003, 22:90 (abstr 359). The results of this multicenter, phase III trial suggest that in patients with stage I or II head and neck squamous cell carcinoma following definitive treatment with radiation therapy or surgery, isotretinoin does not reduce head and neck cancer recurrence or second primary tumors (oral cavity, pharynx, larynx, and lung).
33. Clark LC, Combs GF Jr, Turnbull BW, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996, 276:1957-1963.
34. Blot WJ, Li JY, Taylor RR, et al.: Linxian nutrition intervention trials: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993, 85:1483-1492.
35. Khuri FR, Wu H, Lee JJ, et al.: Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 2001, 7:861-867.
36. Cohen V, Khuri FR: Chemoprevention of lung cancer: current status and future prospects. Cancer Metastasis Rev 2002, 21:349-362.